WuXi AppTec Co., Ltd. (HKG:2359)
116.10
-0.90 (-0.77%)
Sep 3, 2025, 11:45 AM HKT
WuXi AppTec Revenue
WuXi AppTec had revenue of 41.90B CNY in the twelve months ending June 30, 2025, up 15.64% year-over-year. In the year 2024, WuXi AppTec had annual revenue of 37.92B, down -1.97%.
Revenue (ttm)
41.90B CNY
Revenue Growth
+15.64%
P/S Ratio
7.76
Revenue / Employee
1.06M CNY
Employees
39,414
Market Cap
356.39B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 37.92B | -760.22M | -1.97% |
Dec 31, 2023 | 38.68B | -676.78M | -1.72% |
Dec 31, 2022 | 39.35B | 16.45B | 71.84% |
Dec 31, 2021 | 22.90B | 6.37B | 38.50% |
Dec 31, 2020 | 16.54B | 3.66B | 28.46% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 12.52B |
Sino Biopharmaceutical | 33.49B |
Akeso | 2.75B |
WuXi Biologics | 21.98B |
CSPC Pharmaceutical Group | 28.49B |